Minimally Invasive Thoracic Surgery Market Size, Share, Growth, Trends, Application Analysis and Forecast, 2018 to 2025
“Global minimally invasive thoracic surgery market size was valued at USD 3.2 billion in 2016 and is projected to grow at a CAGR of 5.69% by 2025�
The global minimally invasive thoracic surgery market is expected to reach USD 5.3 billion by 2025, based on a new report by Grand View Research, Inc. Minimally Invasive Surgery (MIS) is gaining popularity owing to the reduced risk and trauma associated with these procedures as small incisions decrease post-operative pain that facilitates a speedy recovery. Increasing research and development in this field is another high impact rendering driver of the market. Introduction of novel technologies and devices by the market players have been observed in the recent years. In 2016, Cardiac received the FDA clearance for its MicroCutter XCHANGE 30 surgical stapling device for resection and transection in minimally invasive and open pediatric, urologic and thoracic surgical procedures. In the U.S., lung cancer is a second leading cancer form. According to the American Cancer Society, about 222,500 new lung cancer cases are estimated in 2017. A high number of smokers in the U.S. is a leading cause of cancer prevalence in the region. Smoking is also one of the major risk factors for lung cancer in developing countries. Nearly 80% of the smokers live in middle and low-income countries. This makes developing countries a potential market for thoracic surgeries.
Follow Us: